Journal of Clinical Medicine,
Год журнала:
2022,
Номер
11(3), С. 572 - 572
Опубликована: Янв. 24, 2022
The
most
challenging
aspect
of
Post-Acute
Sequelae
SARS-CoV-2
Infection
(PASC)
or
Long
COVID
remains
for
the
discordance
between
viral
damage
from
acute
infection
in
recent
past
and
susceptibility
without
clear
evidence
post
infectious
inflammation
autoimmune
reactions.
In
this
communication
we
propose
that
disarray
pericytes
plays
a
central
role
emerge
COVID.
We
assume
are
agents
with
"Triple-A"
qualities,
i.e.,
analyze-adapt
advance,
necessary
sustainability
host
homeostasis.
Based
on
view,
further
suggest
may
provide
model
system
to
integrate
theory
complex
adaptive
systems
explore
new
class
maladies
those
currently
not
well
defined
no
remedies.
Vaccines,
Год журнала:
2021,
Номер
9(5), С. 497 - 497
Опубликована: Май 12, 2021
Post-COVID
syndrome
is
increasingly
recognized
as
a
new
clinical
entity
in
the
context
of
SARS-CoV-2
infection.
Symptoms
persisting
for
more
than
three
weeks
after
diagnosis
COVID-19
characterize
post-COVID
syndrome.
Its
incidence
ranges
from
10%
to
35%,
however,
rates
high
85%
have
been
reported
among
patients
with
history
hospitalization.
Currently,
there
no
consensus
on
classification
We
reviewed
published
information
syndrome,
putting
emphasis
its
pathogenesis.
The
pathogenesis
multi-factorial
and
one
mechanism
may
be
implicated
several
manifestations.
Prolonged
inflammation
has
key
role
account
some
neurological
complications,
cognitive
dysfunction,
other
symptoms.
A
multisystem
inflammatory
adults
(MIS-A)
all
ages
also
described
recently,
similarly
children
(MIS-C).
post-infectious
pathogenetic
MIS-A
supported
by
fact
that
established
through
serology
up
third
cases.
Other
mechanisms
are
include
immune-mediated
vascular
thromboembolism,
nervous
system
dysfunction.
Although
current
data
indicating
overwhelming
majority
good
prognosis,
registries
actively
follow
them
needed
order
define
full
spectrum
long-term
outcome.
consensus-based
essential
guide
clinical,
diagnostic,
therapeutic
management.
Further
research
imperative
elucidate
International Journal of Mental Health and Addiction,
Год журнала:
2021,
Номер
21(1), С. 51 - 70
Опубликована: Июль 6, 2021
COVID-19
is
a
new
type
of
trauma
that
has
never
been
conceptually
or
empirically
analyzed
in
our
discipline.
This
study
aimed
to
investigate
the
impact
as
traumatic
stress
on
mental
health
after
controlling
for
individuals'
previous
stressors
and
traumas.
We
utilized
sample
(N
=
1374)
adults
from
seven
Arab
countries.
used
an
anonymous
online
questionnaire
included
measures
stress,
posttraumatic
disorder,
anxiety,
depression,
cumulative
conducted
hierarchical
multiple
regression,
with
anxiety
dependent
variables.
In
first
step,
each
analysis,
we
entered
country,
gender,
age,
religion,
education,
income
independent
variables
(Kira,
Traumatology
7(2):73–86,
2001;
Kira,
Torture,
14:38–44,
2004;
Traumatology,
2021,
https://doi.org/10.1037/trm0000305).
second
traumas
variable.
third
either
one
its
subtypes
(fears
infection,
economic,
lockdown)
Finally,
structural
equation
modeling
PTSD,
predictors
latent
variable
Results
indicated
stressors,
three
subtypes,
were
unique
depression.
Thus,
serious
effects.
Journal of Infection and Public Health,
Год журнала:
2022,
Номер
15(8), С. 856 - 869
Опубликована: Июнь 23, 2022
Several
studies
have
reported
prolonged
symptoms
especially
neurological
following
acute
infection
in
patients
with
COVID-19,
known
as
long
COVID-19.
There
are
only
few
investigating
this
population
and
relatively
less
known,
including
nervous
system
involvement.
A
systematic
review
meta-analysis
of
these
required
to
understanding
the
prevalence
persistent
manifestations
after
Frontiers in Neuroscience,
Год журнала:
2022,
Номер
16
Опубликована: Апрель 22, 2022
The
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2)
has
caused
several
outbreaks
of
highly
contagious
diseases
worldwide.
symptoms
Coronavirus
Disease-19
(COVID-19)
have
been
closely
monitored
and
studied,
while
the
central
nervous
system
(CNS)
peripheral
(PNS)
lesions
induced
by
COVID-19
not
received
much
attention.
Currently,
patients
with
COVID-19-associated
encephalopathy
present
dizziness,
headache,
anxiety
depression,
stroke,
epileptic
seizures,
Guillain-Barre
(GBS),
demyelinating
disease.
exact
pathologic
basis
for
these
neurological
is
currently
known.
Rapid
mutation
SARS-CoV-2
genome
leads
to
appearance
variants
concern
(VOCs),
which
higher
infectivity
virulence.
Therefore,
this
narrative
review
will
focus
on
imaging
assessment
its
VOC.
There
an
increase
in
technologies,
such
as
[18F]fluorodeoxyglucose
positron
emission
tomography
(18F-FDG-PET)
functional
magnetic
resonance
(fMRI),
that
used
observe
changes
brain
microstructure
over
time
recovery.
Medical
pathological
approaches
aimed
at
exploring
associations
between
VOC,
cranial
nerve
abnormal
discharge
shed
light
rehabilitation
process
microstructural
related
SARS-CoV-2,
aid
future
research
our
understanding
treatment
prognosis
encephalopathy.
European journal of medical research,
Год журнала:
2023,
Номер
28(1)
Опубликована: Авг. 30, 2023
Abstract
Background
Coronaviruses
such
as
Severe
Acute
Respiratory
Syndrome
coronavirus
(SARS),
Middle
Eastern
(MERS)
and
Coronavirus
2
(SARS-CoV-2)
are
associated
with
critical
illnesses,
including
severe
respiratory
disorders.
SARS-CoV-2
is
the
causative
agent
of
deadly
COVID-19
illness,
which
has
spread
globally
a
pandemic.
may
enter
human
body
through
olfactory
lobes
interact
angiotensin-converting
enzyme2
(ACE2)
receptor,
further
facilitating
cell
binding
entry
into
cells.
Reports
have
shown
that
virus
can
pass
blood–brain
barrier
(BBB)
central
nervous
system
(CNS),
resulting
in
various
Cell
by
largely
relies
on
TMPRSS2
cathepsin
L,
activate
S
protein.
found
surface
respiratory,
gastrointestinal
urogenital
epithelium,
while
cathepsin-L
part
endosomes.
Aim
The
current
review
aims
to
provide
information
how
infection
affects
brain
function..
Furthermore,
CNS
disorders
infection,
ischemic
stroke,
cerebral
venous
thrombosis,
Guillain–Barré
syndrome,
multiple
sclerosis,
meningitis,
encephalitis,
discussed.
many
probable
mechanisms
paths
involved
developing
cerebrovascular
problems
COVID
patients
thoroughly
detailed.
Main
There
been
reports
cross
where
it
could
cause
illnesses.
Patients
suffering
from
experience
range
neurological
complications,
sleep
disorders,
viral
headaches,
dysgeusia,
cognitive
impairment.
presence
cerebrospinal
fluid
(CSF)
reported.
Health
experts
also
reported
its
cortical
neurons
organoids.
possible
mechanism
infiltration
be
neurotropic,
direct
cytokine
storm-based
pathways.
primary
pathway
for
entrance
brain.
Conclusions
lead
manifestations,
motor
movement
decline.
result
symptoms
diseases,
strokes
thrombosis.
affect
neural
system,
disrupt
function
To
combat
epidemic,
crucial
repurpose
drugs
currently
use
quickly
develop
novel
therapeutics.
Journal of Clinical Medicine,
Год журнала:
2021,
Номер
10(9), С. 1947 - 1947
Опубликована: Май 1, 2021
In
December
2019,
in
Wuhan
(China),
a
highly
pathogenic
coronavirus,
named
SARS-CoV-2,
dramatically
emerged.
This
new
virus,
which
causes
severe
pneumonia,
is
rapidly
spreading
around
the
world,
hence
it
provoked
COVID-19
pandemic.
emergency
launched
by
SARS-CoV-2
also
had,
and
still
has,
devastating
socio-economic
aspects.
Assessing
impact
of
on
vulnerable
groups
people
crucial
for
adaptation
governments'
responses.
Growing
scientific
evidence
suggests
that
essential
to
keep
attention
after
acute
infection;
indeed,
some
clinical
manifestations
are
frequently
present
even
recovery.
There
consensus
need
define
symptoms
persist
infection
disabilities
may
arise
COVID-19.
Recent
reviews,
case
reports,
original
contributions
suggest
various
organs
be
affected,
neurological
about
one
third
patients
with
Neurological
complications
might
include
delirium,
brain
inflammation,
stroke,
nerve
damage.
recent
pandemic,
neurologists
neurobiologists
have
chance
study
key
features
neurology.
Furthermore,
psychological
pandemic
should
not
underestimated,
although
there
currently
no
definition
this
condition.
Life,
Год журнала:
2021,
Номер
11(10), С. 1056 - 1056
Опубликована: Окт. 8, 2021
The
dysfunctional
effects
of
the
coronavirus
disease
2019
(COVID-19)
infection
on
nervous
system
are
established.
manifestation
neuropsychiatric
symptoms
during
and
after
is
influenced
by
neuroinvasive
neurotrophic
properties
SARS-CoV-2
as
well
strong
inflammation
characterised
a
specific
“cytokine
storm”.
Research
suggests
that
immune
response
to
psychological
stressors
related
pandemic
may
cause
chronic
inflammatory
processes
in
body
with
elevated
levels
markers
contributing
intensification
neurodegenerative
processes.
It
suggested
neuroinflammation
associated
central
changes
significantly
contribute
etiopathogenesis
depressive
disorders.
In
addition,
COVID-19
persist
for
up
several
weeks
an
acute
post-COVID-19
syndrome.
Moreover,
previous
knowledge
indicates
among
SSRI
(selective
serotonin
reuptake
inhibitor)
group
antidepressants,
fluoxetine
promising
drug
against
COVID-19.
conclusion,
further
research,
observation
broadening
pathomechanism
impact
potential
complications
necessary.
essential
continue
research
order
assess
long-term
patients
find
new
therapeutic
strategies.
Frontiers in Neurology,
Год журнала:
2023,
Номер
14
Опубликована: Фев. 9, 2023
Post
COVID-19
syndrome
is
determined
as
signs
and
symptoms
that
appear
during
or
after
an
infection
consistent
with
SARS-CoV-2
disease,
persist
for
more
than
12
weeks
are
not
explained
by
alternative
diagnosis.
This
review
presents
the
neuropathological
findings
imaging
in
Neurological
Syndrome:
focal
point
on
manifestations
of
involvement
evident
brain
spine
imaging.
International Journal of Molecular Sciences,
Год журнала:
2021,
Номер
22(21), С. 11920 - 11920
Опубликована: Ноя. 3, 2021
The
2019
novel
coronavirus,
known
as
severe
acute
respiratory
syndrome-coronavirus
2
(SARS-CoV-2)
or
coronavirus
disease
(COVID-19),
is
causing
a
global
pandemic.
virus
primarily
affects
the
upper
and
lower
tracts
raises
risk
of
variety
non-pulmonary
consequences,
most
possibly
fatal
which
are
cardiovascular
problems.
Data
show
that
almost
one-third
patients
with
moderate
form
COVID-19
had
preexisting
comorbidities
such
diabetes
mellitus,
obesity,
hypertension,
heart
failure,
coronary
artery
disease.
SARS-CoV2
causes
hyper
inflammation,
hypoxia,
apoptosis,
renin-angiotensin
system
imbalance
in
cell
types,
endothelial
cells.
Profound
dysfunction
associated
can
be
cause
impaired
organ
perfusion
may
generate
myocardial
injury,
renal
procoagulant
state
resulting
thromboembolic
events.
We
discuss
recent
results
on
involvement
pathogenesis
cardiometabolic
diseases
this
review.
also
provide
insights
treatments
reduce
severity
viral
infection.